MX260807B - Acido lipoteicoico de bacterias de acido lactico y su uso para modular respuestas inmunitarias inducidas por bacterias gram-negativas, bacterias gram-positivas patogenas potenciales. - Google Patents

Acido lipoteicoico de bacterias de acido lactico y su uso para modular respuestas inmunitarias inducidas por bacterias gram-negativas, bacterias gram-positivas patogenas potenciales.

Info

Publication number
MX260807B
MX260807B MXPA03010598A MX260807B MX 260807 B MX260807 B MX 260807B MX PA03010598 A MXPA03010598 A MX PA03010598A MX 260807 B MX260807 B MX 260807B
Authority
MX
Mexico
Prior art keywords
bacteria
gram
lactic acid
immune responses
lipoteichoic
Prior art date
Application number
Other languages
English (en)
Inventor
Vidal Karine
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of MXPA03010598A publication Critical patent/MXPA03010598A/es
Publication of MX260807B publication Critical patent/MX260807B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
MXPA03010598 2001-05-23 2002-04-23 Acido lipoteicoico de bacterias de acido lactico y su uso para modular respuestas inmunitarias inducidas por bacterias gram-negativas, bacterias gram-positivas patogenas potenciales. MX260807B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01201958A EP1260227A1 (en) 2001-05-23 2001-05-23 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
PCT/EP2002/004436 WO2002094296A1 (en) 2001-05-23 2002-04-23 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria

Publications (2)

Publication Number Publication Date
MXPA03010598A MXPA03010598A (es) 2004-03-09
MX260807B true MX260807B (es) 2008-09-25

Family

ID=8180365

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03010598 MX260807B (es) 2001-05-23 2002-04-23 Acido lipoteicoico de bacterias de acido lactico y su uso para modular respuestas inmunitarias inducidas por bacterias gram-negativas, bacterias gram-positivas patogenas potenciales.

Country Status (21)

Country Link
US (3) US20040147010A1 (es)
EP (2) EP1260227A1 (es)
JP (1) JP4738717B2 (es)
KR (1) KR20040018375A (es)
CN (1) CN100502888C (es)
AT (1) ATE394111T1 (es)
AU (1) AU2002338873B8 (es)
BR (1) BR0209975A (es)
CA (1) CA2449403C (es)
DE (1) DE60226436D1 (es)
DK (1) DK1395269T3 (es)
ES (1) ES2305256T3 (es)
IN (1) IN2003DE02242A (es)
MX (1) MX260807B (es)
NO (1) NO20035187L (es)
PL (1) PL366455A1 (es)
PT (1) PT1395269E (es)
RU (1) RU2320356C2 (es)
SG (1) SG101083A1 (es)
WO (1) WO2002094296A1 (es)
ZA (1) ZA200309821B (es)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2408573A (en) * 2003-11-25 2005-06-01 Univ Leicester Assay for the interaction of L-Ficolin with lipoteichoic acid
WO2005079210A2 (en) * 2003-12-04 2005-09-01 Biofilms Strategies, Inc. Methods and compositions for preventing biofilm formations, reducing existing biofilms, and for reducing existing biofilms, and for reducing populations of bacteria
AU2003289209A1 (en) * 2003-12-05 2005-06-24 Japan Allergy Applied Institute Co., Ltd. Antiallergic agent containing ground lotus and/or extract thereof together with lactic acid bacterium
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
JP5224807B2 (ja) * 2004-03-04 2013-07-03 イーエルシー マネージメント エルエルシー ラクトバチルス（Ｌａｃｔｏｂａｃｉｌｌｕｓ）抽出物による皮膚の処置方法
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
JP4726109B2 (ja) * 2005-02-10 2011-07-20 昭和電工株式会社 皮膚外用剤、それを用いる皮膚有害微生物の付着予防方法及び増殖防止方法
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
EP1885383B1 (en) 2005-05-31 2016-09-21 IAMS Europe B.V. Feline probiotic bifidobacteria
AR052472A1 (es) 2005-05-31 2007-03-21 Iams Company Lactobacilos probioticos para felinos
WO2008093303A2 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
US8920814B2 (en) * 2007-03-08 2014-12-30 The Governors Of The University Of Alberta Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections
EP2147091A4 (en) * 2007-04-24 2010-12-08 Kemin Ind Inc ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY WITH LACTOBACILLUS JOHNSONII D115 LARGE SPECTRUM
JP5225652B2 (ja) * 2007-10-29 2013-07-03 雪印メグミルク株式会社 アディポネクチン分泌促進及び／又は減少抑制剤
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2140772A1 (en) * 2008-07-03 2010-01-06 Nestec S.A. Temperature-induced delivery of nutrients by micro-organisms in the gastrointestinal tract
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
CN102245191A (zh) * 2008-12-16 2011-11-16 雀巢产品技术援助有限公司 用于改善口腔健康的组合物和方法
PT2429539T (pt) * 2009-05-11 2017-01-12 Nestec Sa Lactobacilos johnsonii la1 ncc533 não replicativo (cncm i-1225) e distúrbios imunitários
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP2471801A4 (en) * 2009-08-26 2013-12-04 Rna Inc GLYCOLIPIDES DERIVED FROM LIPOTHEICHOIC ACID AND COMPOSITIONS CONTAINING THESE GLYCOLIPIDS
US9504739B2 (en) 2011-03-01 2016-11-29 Quorum Innovations, Llc Method of identifying a biologically-active composition from a biofilm
US9415062B2 (en) 2011-03-03 2016-08-16 Burim N. Ametaj Use of bacterial endotoxins and lipoteichoic acids to improve postpartal health and productivity of dairy cows and their newborns
GB201112091D0 (en) * 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
US20130089638A1 (en) * 2011-10-11 2013-04-11 Mead Johnson Nutrition Company Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes
EP2589387A1 (en) * 2011-11-04 2013-05-08 Lunamed AG Use of a teichoic acid for the treatment of malignant liquor cerebrospinalis in the brain
CN102399733B (zh) * 2011-12-14 2014-07-09 北京大北农科技集团股份有限公司 约氏乳杆菌及其菌剂、应用和预混料
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
US9399048B2 (en) * 2014-03-05 2016-07-26 Asian Probiotics And Prebiotics Ltd Lactic acid bacteria and its applications in immunomodulation and anti-inflammation
CN104161775A (zh) * 2014-05-29 2014-11-26 浙江大学宁波理工学院 来自丁酸梭菌的脂磷壁酸在调节水产动物免疫应答中的用途
CN104161776A (zh) * 2014-05-29 2014-11-26 浙江大学宁波理工学院 来自丁酸梭菌的脂磷壁酸及其调节畜禽免疫应答的用途
JP6427278B2 (ja) 2014-12-23 2018-11-21 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ ｐｉｒｉｎポリペプチド及び免疫モジュレーション
EP3395351A1 (en) 2014-12-23 2018-10-31 4D Pharma Research Limited Immune modulation
US11547125B2 (en) 2015-02-13 2023-01-10 Mars, Incorporated Pet food feeding system
BR112017025005A2 (pt) 2015-06-15 2018-08-07 4D Pharma Research Limited composições compreendendo cepas baterianas
CN107847529B (zh) 2015-06-15 2022-05-03 4D制药研究有限公司 包含细菌菌株的组合物
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PT3650033T (pt) 2015-06-15 2022-05-25 4D Pharma Res Ltd Composições compreendendo estirpes bacterianas
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41013A (fr) 2015-11-20 2017-08-30 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
EA035949B1 (ru) 2016-03-04 2020-09-04 4Д ФАРМА ПиЭлСи Применение композиции, содержащей бактериальный штамм вида blautia hydrogenotrophica, и способ лечения или предотвращения висцеральной гиперчувствительности
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
US10874700B2 (en) 2016-03-31 2020-12-29 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
CN106236826A (zh) * 2016-08-12 2016-12-21 福建万亿店中店电子商务有限责任公司 一种用于阴道疾病辅助治疗的乳酸菌磷壁酸凝胶
JP2020500860A (ja) 2016-11-23 2020-01-16 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティック／プレバイオティックな有効成分を含む消毒薬組成物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
MA48939B1 (fr) 2017-05-22 2021-06-30 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
WO2018215782A1 (en) 2017-05-24 2018-11-29 4D Pharma Research Limited Compositions comprising bacterial strain
HUE053488T2 (hu) 2017-06-14 2021-06-28 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
LT3638271T (lt) 2017-06-14 2021-01-11 4D Pharma Research Limited Kompozicijos, apimančios bakterines padermes
KR102205829B1 (ko) * 2017-06-14 2021-01-21 기초과학연구원 신규한 비피도박테리움 비피덤 균주 및 균주 유래 다당체
MD3600364T2 (ro) 2017-06-14 2020-12-31 4D Pharma Res Ltd Compoziții care conţin tulpină bacteriană din genul Megasphaera și utilizări ale acestora
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
CN111053789A (zh) * 2019-11-26 2020-04-24 湖南营养树生物科技有限公司 调节免疫系统的方法和组合物
CA3163992A1 (en) * 2019-12-27 2021-07-01 Biopolis, S.L. Uses of lipoteichoic acid from bifidobacteria
KR102325947B1 (ko) * 2020-02-05 2021-11-15 주식회사 에이치이엠파마 신규한 락토바실러스 사케이 hem224 균주, 및 상기 균주 또는 이의 배양물을 포함하는 염증 또는 천식의 치료용 조성물
JP2023179810A (ja) * 2020-11-13 2023-12-20 味の素株式会社 ラクトコッカス・ラクチス、ラクトバチルス属に属する微生物、又はこれらの混合微生物を含有する生菌剤及びその製造方法
JP2023128590A (ja) * 2022-03-03 2023-09-14 株式会社アルソア慧央グループ 腸管免疫賦活剤、ＩｇＡ産生促進剤及び遺伝子発現促進剤
CN115068510A (zh) * 2022-05-24 2022-09-20 宁波大学 一种乳杆菌脂磷壁酸的提取方法及其抗炎活性应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6048928A (ja) * 1983-08-26 1985-03-16 Chugai Pharmaceut Co Ltd Ｔνｆ誘起剤
US4678773A (en) * 1983-08-26 1987-07-07 Chugai Seiyaku Kabushiki Kaisha Antitumor agent
JPS6048929A (ja) * 1983-08-26 1985-03-16 Chugai Pharmaceut Co Ltd 抗腫瘍剤
JPS61275217A (ja) * 1985-05-29 1986-12-05 Yakult Honsha Co Ltd グラム陰性桿菌感染症防御剤
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
DE3817762A1 (de) * 1988-05-26 1989-11-30 Sanum Kehlbeck Gmbh & Co Kg Immunstimulierendes mittel aus propionibakterien sowie verfahren zur herstellung desselben
ATE161181T1 (de) * 1992-07-06 1998-01-15 Nestle Sa Lactobacillus acidophilus enthaltende antigastritis-mittel
AU6362594A (en) * 1993-03-10 1994-09-26 Miles Inc. Hyaluronic acid used as a cancer treatment
US6180100B1 (en) * 1994-09-30 2001-01-30 Urex Biotech., Inc. Lactobacillus compositions and methods for treating urinary tract infections
JP3489930B2 (ja) * 1996-03-08 2004-01-26 株式会社ヤクルト本社 がん予防食品
PT818529E (pt) * 1996-07-09 2005-09-30 Nestle Sa Processo de secagem por pulverizacao
EP0862863B9 (en) * 1997-01-09 2009-08-12 Societe Des Produits Nestle S.A. Cereal product containing probiotics
US5998482A (en) * 1997-11-10 1999-12-07 David; Sunil A. Use of synthetic polycationic amphiphilic substances with fatty acid or hydrocarbon substituents as anti-sepsis agents
JP3046303B1 (ja) * 1999-06-24 2000-05-29 明治乳業株式会社 Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ除菌性飲食品
DE19963420A1 (de) * 1999-12-28 2001-07-12 Sebo Gmbh Gewinnung von biologischen Komponenten aus Körperflüssigkeiten

Also Published As

Publication number Publication date
PT1395269E (pt) 2008-06-16
US8329190B2 (en) 2012-12-11
WO2002094296A1 (en) 2002-11-28
SG101083A1 (en) 2006-02-28
PL366455A1 (en) 2005-02-07
ES2305256T3 (es) 2008-11-01
JP2005500267A (ja) 2005-01-06
EP1260227A1 (en) 2002-11-27
ATE394111T1 (de) 2008-05-15
US20140056927A1 (en) 2014-02-27
BR0209975A (pt) 2004-04-06
DK1395269T3 (da) 2008-08-04
AU2002338873B2 (en) 2008-04-10
MXPA03010598A (es) 2004-03-09
KR20040018375A (ko) 2004-03-03
JP4738717B2 (ja) 2011-08-03
RU2320356C2 (ru) 2008-03-27
ZA200309821B (en) 2005-03-18
CN100502888C (zh) 2009-06-24
AU2002338873B8 (en) 2008-05-08
AU2002338873A1 (en) 2002-12-03
DE60226436D1 (de) 2008-06-19
IN2003DE02242A (en) 2006-01-20
RU2003136828A (ru) 2005-03-10
EP1395269B1 (en) 2008-05-07
US20090142375A1 (en) 2009-06-04
CN1525863A (zh) 2004-09-01
NO20035187D0 (no) 2003-11-21
EP1395269A1 (en) 2004-03-10
NO20035187L (no) 2004-01-05
US20040147010A1 (en) 2004-07-29
CA2449403C (en) 2011-11-15
CA2449403A1 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
ZA200309821B (en) Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by Gram-negative bacteria, potential pathogenic gram-positive bacteria.
HUP0202051A2 (hu) Tejsavbaktérium-kombináció és használata fertőzések és gyulladásos folyamatok megelőzésében és/vagy kezelésében
CA2688736C (en) Novel compositions containing lysozyme and c-1/c-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology
ATE485827T1 (de) Ernährungszusammensetzung
BR0113861A (pt) Derivados de ácidos 3-(heteroaril acetamido)-2-oxo-azetidina-1-sulfÈnicos como agentes antibacterianos
HUP9904308A2 (hu) A mupirocin alkalmazása a nasopharynxnak patogén organizmusokkal történő kolonizációjához társuló bakteriális fertőzések kezelésére szolgáló gyógyszerkészítmény előállítására
MX352281B (es) Dihidroxi-clorinas glico-sustituidas y clorinas beta-funcionalizadas para terapia fotodinamica anti-microbiana.
Coenye et al. Biofilms in skin infections: Propionibacterium acnes and acne vulgaris
MY159377A (en) Aqueous suspensions of ciclesonide for nebulisation
BRPI0413509A (pt) uso de antibióticos de quinolona
CN101288769A (zh) 一种用于宠物的杀菌制剂及其制备方法
GB0114672D0 (en) Pharmaceutical formulations and methods of medical treatment
Belal Relevance of bacterial normal flora in antimicrobial resistance and how to overcome this resistance
de Cássia Oliveira et al. Bacteriophage Isolation from Denture Biofilm
CN111479569A (zh) 氯唑西林抑制/预防生物膜形成的用途
WO2022184763A8 (en) Use of galacto-oligosaccharides for providing skin care benefits
Sumida et al. Effectiveness and clinical applications of a safe edible antimicrobial peptide produced by lactic acid bacteria
Snowden Bacterial biofilm formation and immune evasion mechanisms
Notari et al. Ciprofloxacin: a study of usage in pedal infections with case reports
Hassan et al. The Increasing importance of Normal Flora Commensals in Health or Potentially Pathogens for Disease
TH112254A (th) วิธีการสำหรับการป้องกันหรือการบำบัดการติดเชื้อทางเดินหายใจและหูชั้นกลางอักเสบเฉียบพลันในทารก

Legal Events

Date Code Title Description
FG Grant or registration